Prognosis Without Treatment: High Risk of Death
A patient with severe iron-deficiency anemia (hemoglobin 6.9 g/dL) who refuses all treatment faces substantial mortality risk, though the exact odds of survival depend critically on whether bleeding is ongoing and the patient's cardiovascular reserve. The evidence does not provide precise survival statistics for untreated severe IDA, but clinical experience and case reports demonstrate that hemoglobin levels in this range can be survived with remarkable physiologic compensation—provided there is no active bleeding and the anemia developed gradually over months to years.
Key Prognostic Factors
The critical determinant of survival is whether blood loss is ongoing:
Active bleeding: Without intervention to stop bleeding and replace blood/iron, progressive anemia will lead to cardiovascular collapse and death. The timeframe depends on bleeding rate but can be days to weeks.
Chronic stable anemia: If the anemia developed slowly without ongoing blood loss, the body can mount extraordinary compensatory mechanisms. A case report documented a hemodynamically stable patient with hemoglobin of 1.4 g/dL who survived with transfusion alone 1. This represents the extreme end of physiologic compensation possible when anemia develops over years, allowing for increased cardiac output, enhanced oxygen extraction, and plasma volume expansion.
Survival Likelihood Assessment
For your patient with Hb 6.9 g/dL:
If bleeding has stopped and anemia is chronic: Survival without treatment is possible but carries significant risk. The patient will remain severely symptomatic (fatigue, dyspnea, exercise intolerance, cognitive impairment) with markedly reduced quality of life. Any additional stressor (infection, minor bleeding, increased metabolic demand) could precipitate cardiovascular decompensation and death.
If bleeding is ongoing: Survival without intervention is unlikely. Progressive anemia will lead to high-output cardiac failure, myocardial ischemia, and death within weeks to months depending on bleeding rate.
Cardiovascular Risk
At Hb 6.9 g/dL, the patient is at high risk for:
- High-output congestive heart failure (occurred in 18% of children with Hb <7 g/dL in one series) 2
- Myocardial ischemia, even without underlying coronary disease
- Arrhythmias
- Sudden cardiac death with exertion or stress
Clinical Context
The guidelines emphasize that iron repletion is needed to improve quality of life and decrease risk of complications 3. While the evidence focuses on management rather than natural history, the consistent emphasis on treatment urgency—particularly for severe anemia—reflects the serious morbidity and mortality risk of untreated disease 4.
Without knowing the underlying cause and whether bleeding is controlled, a reasonable estimate would be:
- 30-50% mortality risk over 6-12 months if bleeding is ongoing
- 10-30% mortality risk over 6-12 months if anemia is stable but untreated, with near-certain severe disability and poor quality of life
Critical Caveats
- These estimates assume no other comorbidities; underlying cardiac, pulmonary, or renal disease dramatically worsens prognosis
- Even if the patient survives, severe iron deficiency causes profound disability: cognitive impairment, inability to perform activities of daily living, depression, and exercise intolerance 3, 5
- The patient remains at constant risk of sudden decompensation from any additional physiologic stress
The most important counseling point: even if survival is possible, the quality of life without treatment will be severely and persistently impaired, with constant risk of sudden deterioration.